Cyclerion Therapeutics, Inc. (CYCN) SEC Filings — 2024
14 SEC filings for Cyclerion Therapeutics, Inc. (CYCN) in 2024.
Filings
- Cyclerion Therapeutics Files 8-K: Material Agreement — 8-K · Dec 17, 2024
- Cyclerion Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Cyclerion Therapeutics Files 8-K — 8-K · Aug 7, 2024
- Cyclerion Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Cyclerion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jul 12, 2024
- Cyclerion Therapeutics Files 8-K — 8-K · Jun 14, 2024
- Cyclerion Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Cyclerion Therapeutics, Inc. Announces Annual Meeting of Shareholders on June 14, 2024 — DEF 14A · Apr 29, 2024
- Cyclerion Therapeutics Files 8-K — 8-K · Apr 18, 2024
- Cyclerion Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Cyclerion Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Artal International Updates Cyclerion Therapeutics Stake — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Hold 6.66% Stake in Cyclerion Therapeutics — SC 13G/A · Feb 9, 2024
- Slate Path Capital LP Holds 357,880 Shares of Cyclerion Therapeutics — SC 13G/A · Jan 22, 2024